173 related articles for article (PubMed ID: 30784161)
1. Evaluation of a rare glucose-dependent insulinotropic polypeptide receptor variant in a patient with diabetes.
Jacobi SF; Khajavi N; Kleinau G; Teumer A; Scheerer P; Homuth G; Völzke H; Wiegand S; Kühnen P; Krude H; Gong M; Raile K; Biebermann H
Diabetes Obes Metab; 2019 May; 21(5):1168-1176. PubMed ID: 30784161
[TBL] [Abstract][Full Text] [Related]
2. Association of variants in gastric inhibitory polypeptide receptor gene with impaired glucose homeostasis in obese children and adolescents from Berlin.
Sauber J; Grothe J; Behm M; Scherag A; Grallert H; Illig T; Hinney A; Hebebrand J; Wiegand S; Grüters A; Krude H; Biebermann H
Eur J Endocrinol; 2010 Aug; 163(2):259-64. PubMed ID: 20516203
[TBL] [Abstract][Full Text] [Related]
3. Genetically Predicted Glucose-Dependent Insulinotropic Polypeptide (GIP) Levels and Cardiovascular Disease Risk Are Driven by Distinct Causal Variants in the
Bowker N; Hansford R; Burgess S; Foley CN; Auyeung VPW; Erzurumluoglu AM; Stewart ID; Wheeler E; Pietzner M; Gribble F; Reimann F; Bhatnagar P; Coghlan MP; Wareham NJ; Langenberg C
Diabetes; 2021 Nov; 70(11):2706-2719. PubMed ID: 34426508
[TBL] [Abstract][Full Text] [Related]
4. Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents.
Gasbjerg LS; Gabe MBN; Hartmann B; Christensen MB; Knop FK; Holst JJ; Rosenkilde MM
Peptides; 2018 Feb; 100():173-181. PubMed ID: 29412817
[TBL] [Abstract][Full Text] [Related]
5. Discovery of amino acid variants in the human glucose-dependent insulinotropic polypeptide (GIP) receptor: the impact on the pancreatic beta cell responses and functional expression studies in Chinese hamster fibroblast cells.
Almind K; Ambye L; Urhammer SA; Hansen T; Echwald SM; Holst JJ; Gromada J; Thorens B; Pedersen O
Diabetologia; 1998 Oct; 41(10):1194-8. PubMed ID: 9794107
[TBL] [Abstract][Full Text] [Related]
6. Spatiotemporal regulation of GIPR signaling impacts glucose homeostasis as revealed in studies of a common GIPR variant.
Yammine L; Picatoste B; Abdullah N; Leahey RA; Johnson EF; Gómez-Banoy N; Rosselot C; Wen J; Hossain T; Goncalves MD; Lo JC; Garcia-Ocaña A; McGraw TE
Mol Metab; 2023 Dec; 78():101831. PubMed ID: 37925022
[TBL] [Abstract][Full Text] [Related]
7. Disruption of GIP/GIPR axis in human adipose tissue is linked to obesity and insulin resistance.
Ceperuelo-Mallafré V; Duran X; Pachón G; Roche K; Garrido-Sánchez L; Vilarrasa N; Tinahones FJ; Vicente V; Pujol J; Vendrell J; Fernández-Veledo S
J Clin Endocrinol Metab; 2014 May; 99(5):E908-19. PubMed ID: 24512489
[TBL] [Abstract][Full Text] [Related]
8. Association of incretin receptors genetic polymorphisms with type 2 diabetes mellitus in Egyptian patients.
Shalaby SM; Zidan HE; Shokry A; Saeed J; El-Sokkary RH
J Gene Med; 2017 Sep; 19(9-10):. PubMed ID: 28744963
[TBL] [Abstract][Full Text] [Related]
9. TCF1 links GIPR signaling to the control of beta cell function and survival.
Campbell JE; Ussher JR; Mulvihill EE; Kolic J; Baggio LL; Cao X; Liu Y; Lamont BJ; Morii T; Streutker CJ; Tamarina N; Philipson LH; Wrana JL; MacDonald PE; Drucker DJ
Nat Med; 2016 Jan; 22(1):84-90. PubMed ID: 26642437
[TBL] [Abstract][Full Text] [Related]
10. A functional amino acid substitution in the glucose-dependent insulinotropic polypeptide receptor (GIPR) gene is associated with lower bone mineral density and increased fracture risk.
Torekov SS; Harsløf T; Rejnmark L; Eiken P; Jensen JB; Herman AP; Hansen T; Pedersen O; Holst JJ; Langdahl BL
J Clin Endocrinol Metab; 2014 Apr; 99(4):E729-33. PubMed ID: 24446656
[TBL] [Abstract][Full Text] [Related]
11. A novel GIP receptor splice variant influences GIP sensitivity of pancreatic beta-cells in obese mice.
Harada N; Yamada Y; Tsukiyama K; Yamada C; Nakamura Y; Mukai E; Hamasaki A; Liu X; Toyoda K; Seino Y; Inagaki N
Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E61-8. PubMed ID: 17971513
[TBL] [Abstract][Full Text] [Related]
12. Association analyses of GIP and GIPR polymorphisms with traits of the metabolic syndrome.
Nitz I; Fisher E; Weikert C; Burwinkel B; Li Y; Möhlig M; Boeing H; Schreiber S; Schrezenmeir J; Döring F
Mol Nutr Food Res; 2007 Aug; 51(8):1046-52. PubMed ID: 17624916
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in the glucose-dependent insulinotropic polypeptide receptor modifies the association between carbohydrate and fat intake and risk of type 2 diabetes in the Malmo Diet and Cancer cohort.
Sonestedt E; Lyssenko V; Ericson U; Gullberg B; Wirfält E; Groop L; Orho-Melander M
J Clin Endocrinol Metab; 2012 May; 97(5):E810-8. PubMed ID: 22399504
[TBL] [Abstract][Full Text] [Related]
14. The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes.
Regazzo D; Barbot M; Scaroni C; Albiger N; Occhi G
Rev Endocr Metab Disord; 2020 Mar; 21(1):165-183. PubMed ID: 31933128
[TBL] [Abstract][Full Text] [Related]
15. A naturally occurring GIP receptor variant undergoes enhanced agonist-induced desensitization, which impairs GIP control of adipose insulin sensitivity.
Mohammad S; Patel RT; Bruno J; Panhwar MS; Wen J; McGraw TE
Mol Cell Biol; 2014 Oct; 34(19):3618-29. PubMed ID: 25047836
[TBL] [Abstract][Full Text] [Related]
16. [The role of single nucleotide polymorphisms in GIPR gene in the changes of secretion in hormones and adipokines in patients with obesity with type 2 diabetes].
Skuratovskaia DA; Vulf MA; Kirienkova EV; Mironyuk NI; Zatolokin PA; Litvinova LS
Biomed Khim; 2018 Mar; 64(2):208-216. PubMed ID: 29723152
[TBL] [Abstract][Full Text] [Related]
17. Insights into agonist-elicited activation of the human glucose-dependent insulinotropic polypeptide receptor.
Yuliantie E; van der Velden WJC; Labroska V; Dai A; Zhao F; Darbalaei S; Deganutti G; Xu T; Zhou Q; Yang D; Rosenkilde MM; Sexton PM; Wang MW; Wootten D
Biochem Pharmacol; 2021 Oct; 192():114715. PubMed ID: 34339714
[TBL] [Abstract][Full Text] [Related]
18. Structural and pharmacological characterization of novel potent and selective monoclonal antibody antagonists of glucose-dependent insulinotropic polypeptide receptor.
Ravn P; Madhurantakam C; Kunze S; Matthews E; Priest C; O'Brien S; Collinson A; Papworth M; Fritsch-Fredin M; Jermutus L; Benthem L; Gruetter M; Jackson RH
J Biol Chem; 2013 Jul; 288(27):19760-72. PubMed ID: 23689510
[TBL] [Abstract][Full Text] [Related]
19. Role of G protein-coupled receptor kinases in glucose-dependent insulinotropic polypeptide receptor signaling.
Tseng CC; Zhang XY
Endocrinology; 2000 Mar; 141(3):947-52. PubMed ID: 10698169
[TBL] [Abstract][Full Text] [Related]
20. Weight-loss diets modify glucose-dependent insulinotropic polypeptide receptor rs2287019 genotype effects on changes in body weight, fasting glucose, and insulin resistance: the Preventing Overweight Using Novel Dietary Strategies trial.
Qi Q; Bray GA; Hu FB; Sacks FM; Qi L
Am J Clin Nutr; 2012 Feb; 95(2):506-13. PubMed ID: 22237064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
